Article Text

Download PDFPDF
CASE REPORT
Case of primary Sjogren’s syndrome preceded by dystonia
  1. Kerime Ararat1,
  2. Idanis Berrios2,
  3. Anas Hannoun1,
  4. Carolina Ionete3
  1. 1Department of Medicine, Neurology, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  2. 2Department of Neurology, University of Massachusetts School of Medicine, Worcester, Massachusetts, USA
  3. 3Neurology, University of Massachusetts, Worcester, Massachusetts, USA
  1. Correspondence to Dr Idanis Berrios, idanis.berrios{at}gmail.com

Summary

There are only six cases in literature that describe development of dystonia with Sjogren’s syndrome (SS). We describe a case of a 43-year-old woman who presented with symptoms including movement disorder, sensory neurogenic bladder, sensory loss and neuropathic pain, migraine like headaches, musculoskeletal pain, Raynaud’s phenomenon and dysautonomia. Symptoms started in 2000, with weakness that progressed to dystonia in 2003. Diagnostic work-up was inconclusive with negative inflammatory serologies, cerebrospinal fluid and MRI for many years. After patient developed sicca syndrome with dry eyes and mouth in 2009, her rheumatoid factor titre was elevated (550 IU/mL), erythrocyte sedimentation rate, anti-Sjogrens syndrome-related antigen A (anti-Ro/SSA) and anti-SSB/La: anti-Sjogrens syndrome-related antigen B (anti-La/SSB) became positive. Lip biopsy confirmed diagnosis of SS. She was diagnosed with primary SS with neurological involvement. Her symptoms responded well to intravenous methylprednisolone. Symptoms stabilised with trials of immune-suppressive therapy. This is a case that demonstrates the delay of diagnosing SS with preceding unique neurological association.

  • musculoskeletal and joint disorders
  • movement disorders (other than Parkinsons)
  • Sjogren’s syndrome

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors KA participated in data gathering, review of literature, writing and reviewing the manuscript. IB participated in data gathering, review of literature, writing and reviewing the manuscript. AH participated in data gathering, writing and reviewing the manuscript. CI participated in data gathering, review of literature, writing and reviewing the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests CI: Biogen Idec and Genzyme. She has received compensations for consulting and advisory boards from Genzyme and TEVA. IB has received compensation for consulting in advisory board from Genzyme.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.